Keywords
Escherichia coli
Congo Red Agar Method
Clinical vs Non-clinical
How to Cite
Abstract
Majority of bacterial communities exist as biofilms and these contribute to the survival of the bacteria. Biofilm development has been associated with protection from adverse environmental conditions and resistance to harmful agents. Generally, however data on biofilm-forming potential of bacteria in Nigeria is sparse. This study was therefore aimed at analyzing variations in biofilm-forming potential of Escherichia coli from various sources in Port Harcourt, Nigeria. Previously characterized clinical (30) and non-clinical (30) E. coli isolates were assessed for their biofilm-forming potential using the Congo Red agar method and variations in this potential determined as weak, moderate or strong. Majority of isolates (67%) had the potential to form biofilms but only 40% of isolates exhibiting biofilm-forming potential were from clinical sources. Isolates exhibited variable degrees of biofilm-forming potential, with only non-clinical isolates exhibiting strong potential. Majority of both clinical and non-clinical isolates (68.7% and 88% respectively) exhibited moderate biofilm-forming potential. The higher occurrence of E. coli exhibiting biofilm-forming potential among non-clinical isolates possibly reflects the essential role biofilms play in the survival of bacteria in nature, but not in infection cases. This study reports on a high level association between the isolates and biofilm production and highlights differences in the abilities of biofilm production between clinical and non-clinical isolates.
References
Adamus-Bialek, W., Kubiak, A., Czerwonka, G. (2015). Analysis of uropathogenic Escherichia coli biofilm formation under different growth conditions. Acta Biochimica Polonica, 62(4), 765 – 771.
Agarwal, A., Jain, A. (2013). Glucose & sodium chloride induced biofilm production & ica operon in clinical isolates of staphylococci. The Indian Journal of Medical Research, 138(2), 262 – 266.
Bajpai, T., Varma, M., Bhatambare, G. S., Pandey, M. (2016). Escherichia coli biofilms: Accepting the therapeutic challenges. International Journal of Health & Allied Sciences, 5(4), 204 – 209.
Banerjee, A., Bardhan, R., Chowdhury, M., Joardar, S. N., Isore, D. P., Batabayl, K., Dey, S., Sar, T. K., Bandyopadhyay, S., Dutta, T. K., Samanta, I. (2019). Characterization of beta-lactamase and biofilm producing Enterobacteriaceae isolated from organized and backyard farm ducks. Letters in Applied Microbiology, 69(2), 110 – 115.
Barbosa, J., Borges, S., Camilo, R., Magalhaes, R., Ferreira, V., Santos, I., Silva, J., Almeida, G., Teixeira, P. (2013). Biofilm formation among clinical and food isolates of Listeria monocytogenes. International Journal of Microbiology, 524975.
Costerton, J. W., Stewart, P. S., Greenberg, E.P. (1999). Bacterial biofilms: a common cause of persistent infections. Science, 284(5418), 1318 – 1322.
Darwish, S.F., Asfour, H.A. (2013). Investigation of biofilm-forming ability in Staphylococci causing bovine mastitis using phenotypic and genotypic assays. The Scientific World Journal, 378492, 1– 9.
DePas, W. H., Syed, A. K., Sifuentes, M., Lee, J. S., Warshaw, D., Saggar, V., Csankovszki, G., Boles, B.R., Chapman, M.R. (2014). Biofilm formation protects Escherichia coli against killing by Caenorhabditis elegans and Myxococcus xanthus. Applied and Environmental Microbiology, 80(22), 7079 – 7087.
Donlan, R.M., Costerton, J.W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews, 15(2), 167–193.
Hancock, V., Ferrieres, L., Klemm, P. (2007). Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiology Letters, 267(1), 30 – 37.
Iorio, N. L., Lopes, A. P., Schuenck, R. P., Barcellos, A. G., Olendzki, A. N., Lopez, G. L., dos Santos, K. R. (2011). A combination of methods to evaluate biofilm production may help to determine the clinical relevance of Staphylococcus in blood cultures. Microbiology and Immunology, 55(1), 28 – 33.
Mathur, T., Singhal, S., Khan, S., Upadhyay, D. J., Fatma, T., Rattan, A. (2006). Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian Journal of Medical Microbiology, 24(1), 25 – 29.
Moscoso, M., García, E., López, R. (2009). Pneumococcal biofilms. International Microbiology, 12, 77 – 85.
Otokunefor, K., Osogho, V.O., Nwankwo C.P. (2019). Escherichia coli as possible agents of spread of multidrug resistance. Annals of Science and Technology, 4(1), 16 – 21.
Ochi, P., Otokunefor, K., Abu, G. (2020). Diversity of biofilm producing bacteria in a drinking water distribution system in a sub-urban community in South-South Nigeria. World Journal of Biomedical Research, 7(1), 8 – 14.
Sauer, K., Rickard, A.H., Davies, D.G. (2007). Biofilms and Biocomplexity. Microbe, 2, 347 – 353.
Schiebel, J., Böhm, A., Nitschke, J., Burdukiewicz, M., Weinreich, J., Ali, A., Roggenbuck, D., Rödiger, S., Schierack, P. (2017). Genotypic and phenotypic characteristics associated with biofilm formation by human clinical Escherichia coli isolates of different pathotypes. Applied and Environmental Microbiology, 83(24), e01660-17.
Sharma, G., Sharma, S., Sharma, P., Chandola, D., Dang, S., Gupta, S., Gabrani, R. (2016). Escherichia coli biofilm: development and therapeutic strategies. Journal of Applied Microbiology, 121(2), 309 – 319.
Tajbakhsh, E., Ahmadi, P., Abedpour-Dehkordi, E., Arbab-Soleimani, N., Khamesipour F. (2016). Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran. Antimicrobial Resistance & Infection Control, 5(1), 11.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2020 Array